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Insulin action in adipose tissue is 
crucial for whole-body glucose homeostasis, 
with insulin resistance being a major risk factor 
for metabolic diseases such as type 2 diabetes. 
Recent studies have proposed mitochondrial 
oxidants as a unifying driver of adipose insulin 
resistance, serving as a signal of nutrient 
excess. However, neither the substrates for nor 
sites of oxidant production are known. Since 
insulin stimulates glucose utilisation, we 
hypothesised that glucose oxidation would fuel 
respiration, in turn generating mitochondrial 
oxidants. This would impair insulin action, 
limiting further glucose uptake in a negative 
feedback loop of ‘glucose-dependent’ insulin 
resistance. Using primary rat adipocytes and 
cultured 3T3-L1 adipocytes, we observed that 
insulin increased respiration, but notably this 
occurred independently of glucose supply. In 
contrast, glucose was required for insulin to 
increase mitochondrial oxidants. Despite rising 
to similar levels as when treated with other 
agents that cause insulin resistance, glucose-
dependent mitochondrial oxidants failed to 
cause insulin resistance. Subsequent studies 
revealed a temporal relationship whereby 
mitochondrial oxidants needed to increase 
before the insulin stimulus to induce insulin 
resistance. Together, these data reveal that a) 
adipocyte respiration is principally fuelled from 
non-glucose sources, b) there is a disconnect 
between respiration and oxidative stress, 
whereby mitochondrial oxidant levels do not 
rise with increased respiration unless glucose is 
present, and c) mitochondrial oxidative stress 
must precede the insulin stimulus to cause 
insulin resistance, explaining why short-term 
insulin-dependent glucose utilisation does not 
promote insulin resistance. These data provide 
additional clues to mechanistically link nutrient 
excess to adipose insulin resistance. 
 
 
Adipose tissue is a key nutrient sensor 
in mammals (1). Being highly sensitive to 
insulin, adipocytes respond to nutrient replete 
conditions by increasing energy intake and 
storage as lipid. Conversely, under nutrient 
excess, adipocytes become insulin resistant, 
leading to increased lipid utilisation and 
reduced glucose intake. Indeed, impaired 
glucose uptake into adipose tissue is one of the 
earliest defects observed in whole-body insulin 
resistance, in both rodents and humans (e.g., (2-
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4)). Furthermore, knocking out GLUT4 
specifically in the adipose tissue results in 
whole-body insulin resistance in mice (5). 
Thus, adipocyte insulin sensitivity appears 
critical for whole-body glucose homeostasis. 
Insulin resistance in adipose tissue can 
be caused by numerous insults such as chronic 
hyperinsulinaemia, inflammation, and 
corticosteroids. Each of these have been 
examined in isolation through in vivo (mouse) 
and in vitro (adipocyte) models (e.g., (6,7)), 
revealing that they all produce mitochondrial 
oxidants (mitoROS) as a potential unifying 
cause of insulin resistance (reviewed in (8)). 
Although impaired mitochondrial function has 
been observed in insulin resistance (9,10), we 
have recently shown that acute treatment with 
mitochondrial-targeted paraquat (mPQ) 
increased mitoROS and caused insulin 
resistance, without impacting mitochondrial 
respiration (11). This supports the notion that 
mitoROS alone, without defects in 
mitochondrial respiration, is sufficient to cause 
insulin resistance. This raised the possibility 
that under physiological circumstances, insulin 
resistance may arise without defects in 
mitochondrial respiration, but rather as a result 
of oxidation of specific substrates (e.g., 
glucose, fatty acids) generating mitoROS. This 
suggests that mitoROS might represent a 
mechanistic sensor for nutrient excess (12), 
particularly in the adipocyte.  
Since insulin potently promotes 
glucose uptake into adipocytes, we considered 
the role of glucose utilisation in adipose insulin 
resistance. We have previously observed that 
insulin stimulates glucose oxidation (13), 
glucose-fuelled TCA cycle flux (Quek et al., 
under review), and respiration (14) in 
adipocytes. Thus, we hypothesised that insulin 
stimulates respiration and subsequent mitoROS 
production in a glucose-dependent manner, 
with insulin resistance stemming from glucose 
oversupply. Such ‘glucose-dependent’ insulin 
resistance would limit further glucose uptake as 
a form of negative feedback. 
Using respirometry and metabolic 
labelling, we found that glucose was not 
required for insulin-stimulated respiration in 
cultured and primary adipocytes. In contrast, 
the insulin-stimulated increase in mitoROS was 
glucose-dependent. This presents a 
physiological disconnect between 
mitochondrial respiration and oxidative stress – 
although both increase in response to insulin, 
they have distinct substrate requirements. 
Furthermore, insulin-stimulated oxidant 
generation did not cause insulin resistance, at 
least acutely, despite mitoROS rising to levels 
observed with other agents that induce insulin 
resistance (11). This was because mitoROS 
needed to increase prior to the insulin stimulus, 
demonstrating that the timing of oxidative 
stress is crucial in the development of insulin 
resistance. These observations provide 
additional clues to mechanistically link nutrient 
excess to adipose insulin resistance. 
 
RESULTS 
Glucose is dispensable for insulin-responsive 
respiration 
 In this study, we sought to understand 
the role of glucose metabolism in adipose 
insulin resistance. We hypothesised that insulin 
resistance was caused by mitoROS generated 
from increased glucose metabolism. Since 
mitoROS is generated by enzymes that 
participate in mitochondrial respiration, we 
reasoned that glucose would fuel insulin-
stimulated respiration to generate mitoROS. 
Thus, in the first instance, we examined the role 
of glucose in adipocyte respiration.  
We delineated glucose metabolism 
from insulin action using galactose, a ‘no 
glucose’ sugar analogue previously shown to 
impair glycolysis (e.g., (15-17)). We confirmed 
that galactose ablated insulin-stimulated lactate 
production (Fig 1A). However, contrary to our 
hypothesis, insulin increased respiration 
(oxygen consumption in intact cells) both in the 
presence and absence of glucose (Fig 1B). In 
contrast, both glucose and insulin were required 
for maximal respiration, induced by a maximal 
dose of the mitochondrial uncoupler (BAM15). 
This suggests that insulin-dependent glucose 
metabolism can fuel respiration, but is not 
necessary for respiration under insulin-
stimulated conditions.  
One possibility is that insulin 
stimulates respiration by different mechanisms 
in the presence and absence of glucose. For 
instance, glucose utilisation may generate more 
reducing equivalents, increasing the proton 
gradient and respiration (increased respiration 
through increased supply). Alternatively, 
respiration would also increase in response to 
higher energy demand, which may manifest as 
a depleted proton gradient in the absence of 
glucose, if glucose is required for insulin-
stimulated respiration.  Thus, we examined 













mitochondrial membrane potential (MMP), a 
surrogate for the proton gradient. Insulin did not 
alter MMP in the presence of glucose (p>0.05, 
two-way ANOVA comparing glucose ± insulin 
over time). Removing glucose led to a reduction 
in MMP (~2% difference between 
galactose/insulin versus glucose/insulin; 
p<0.01, two-way ANOVA). However, this 
change was mild in comparison to hypo- or 
hyperpolarisation observed with BAM15 and 
oligomycin, respectively (Fig 1C). This 
suggests that substrate supply and energy 
demand are synchronised in response to insulin, 
without significant energetic imbalance, even in 
the absence of glucose.  
We next sought to translate our 
findings ex vivo. Since adipose tissue consists 
of various cell-types in addition to adipocytes 
(1), we tested whether glucose was required for 
respiration in mature adipocytes isolated from 
rat adipose tissue. We confirmed that galactose 
blunted insulin-responsive lactate levels (Fig 
1D). With this tool, we found that insulin 
slightly increased respiration (Fig 1E), but this 
did not require glucose except in the presence 
of the mitochondrial uncoupler, FCCP (Fig 1F). 
Lower doses of FCCP had little effect on 
respiration (data not shown). Overall, this 
demonstrates that our findings in cultured 
adipocytes are conserved in primary adipocytes 
ex vivo. 
 
Glucose only contributes a portion of 
respiration-derived CO2 
Given insulin could stimulate 
respiration without glucose, we predicted that 
glucose would not be a significant contributor 
to respiration-derived CO2, i.e. CO2 from 
pyruvate dehydrogenase (PDH) and the Krebs 
cycle. It is theoretically possible to calculate 
this from the JO2 (respiration rate) if glucose is 
the sole substrate (18). However, there are other 
substrates present in our experiments, such as 
amino acids in the media and fatty acids from 
intracellular lipid stores. Each substrate varies 
in their respiratory quotient (CO2 produced/O2 
consumed), rendering this approach 
challenging.  
To overcome this, we measured JO2 
from cultured adipocytes using the XFp 
Extracellular Flux Analyzer (Seahorse 
Biosciences), which simultaneously measures 
the extracellular media acidification rate 
(ECAR) within the same experiment (Fig S1A). 
Importantly, ECAR is influenced by not only 
lactate production, but also bicarbonate formed 
by CO2 production (18). We utilised this to 
calculate the contribution of glucose to cellular 
respiration (Fig 1G, detailed in the 
Experimental Procedures). Briefly, we used the 
buffering capacity of the media (Fig S1B) to 
convert the ECAR into the proton production 
rate. Next, we subtracted the lactate production 
rate from the proton production rate to obtain 
ECAR due to CO2, from which we inferred the 
total CO2 production (Fig 1H). Finally, we 
compared this value to the incorporation of 
(14C-labelled) glucose into CO2, determining 
that glucose contributes only 19.8% of 
respiration-derived CO2 under insulin 
stimulation. These experiments were conducted 
in the presence of bicarbonate, which we have 
previously found to influence cellular 
respiration (14) In the absence of bicarbonate, 
we found a similar contribution of glucose to 
respiration-derived CO2 (26.8%, data not 
shown).  
Thus, glucose contributes a relatively 
minor portion of the oxidisable carbon for 
cellular respiration under insulin-stimulated 
conditions. Conversely, insulin can stimulate 
adipocyte respiration without glucose (Fig 
1B,1F). Collectively, this suggests that glucose 
is dispensable for the increase in mitochondrial 
respiration upon insulin exposure. 
 
Glucose is required for insulin-dependent 
mitoROS production 
Since respiratory complexes also 
participate in mitoROS production (e.g., 
(19,20)), this raised the possibility that insulin 
treatment may similarly increase mitoROS 
levels independently of insulin-stimulated 
glucose metabolism. To maximise glucose 
oxidation, we utilised dichloroacetate (DCA), 
which causes the dephosphorylation of 
pyruvate dehydrogenase to promote the activity 
of this enzyme (21). Interestingly, although 
DCA rapidly decreased media acidification 
(Fig 2A), DCA treatment had little effect on 
global respiration (Fig 2B), even under 
maximal bioenergetic demand (BAM15). This 
provided further evidence that global 
respiration is not influenced by changes in 
glucose flux.  
We treated adipocytes with insulin in 
the presence or absence of glucose and DCA. 
We initially utilised matrix-roGFP, a 
mitochondrially-targeted ROS-sensitive probe, 
which did not exhibit substantial changes in 













signal upon treatment with either insulin or 
mPQ (Fig S2A-B). Subsequently, we assessed 
the dimer/monomer status of peroxiredoxin 3 
(PRDX3) and PRDX2, which are robust, 
sensitive indicators of relative oxidant exposure 
in the mitochondria and cytosol, respectively 
(11). For instance, pre-treatment with 
antimycin A significantly increased PRDX3 
dimerisation (Fig 2C, first two lanes; Fig 2D), 
but had a less pronounced effect on PRDX2 
dimerisation (Fig 2C,D; p ~ 0.060 vs control, 
two-sample t-test) – this demonstrates that 
antimycin A more readily increases mitoROS, 
consistent with its known mechanism of action.
 Insulin increased PRDX3 dimerisation, 
but only when glucose was present (Fig 2C,D). 
This was not due to an impairment of insulin 
signalling in the absence of glucose, as 
indicated by similar levels of phosphorylation 
of Akt kinase and its substrate, AS160 (Fig 
2C,E). The insulin- and glucose-dependent 
increase in PRDX3 dimerisation was enhanced 
in the presence of DCA, which caused a 
sustained reduction in PDH phosphorylation 
throughout the time-course (Fig 2C,E). In 
contrast, the change in PRDX2 dimerisation 
was less consistent over time (Fig 2C,D). 
Overall, these data demonstrate that insulin 
increases mitoROS levels in a glucose-
dependent manner.  
Consequently, we examined the 
sensitivity of mitoROS to glucose uptake. As 
observed previously (21), glucose uptake 
increased with insulin and higher media glucose 
concentrations (Fig S2C). PRDX3 dimerisation 
also increased under these conditions (Fig 
2F,G), particularly when physiological glucose 
concentrations (and the Km of GLUT4 (22)) 
were reached. Inhibiting glucose uptake with 
cytochalasin B (Fig S2C) reduced PRDX3 
dimerisation (Fig 2F,G) but did not affect 
respiration (Fig S2D). Furthermore, plotting 
PRDX3 dimerisation against glucose uptake in 
insulin-stimulated adipocytes revealed a 
sigmoidal trend (Fig 2H). This suggests that 
substantial PRDX3 dimerisation occurs once a 
threshold of glucose uptake is reached. Thus, 
mitoROS is sensitive to insulin-stimulated 
glucose uptake. 
 
Glucose-dependent mitoROS does not cause 
insulin resistance 
These data are consistent with the 
notion that glucose-dependent mitoROS is an 
endogenous signal to cause insulin resistance 
under conditions of excess nutrient supply (Fig 
3A). If true, we would predict that sustained 
insulin exposure would increase glucose 
oxidation, mitoROS, and lead to acute insulin 
resistance. Furthermore, this would be 
exacerbated in the presence of DCA.  
Thus, we exposed adipocytes to 
insulin, with or without DCA (Fig 3B). We 
included mPQ as a positive control for 
specifically increasing mitochondrial oxidant 
levels and causing insulin resistance (Fig S2E, 
(11)), and the thioreductase inhibitor, 
auranofin, as a control for PRDX3 dimerisation. 
MitoROS levels rose with prolonged insulin 
treatment (Fig 3C), and co-treatment with DCA 
and insulin increased mitoROS to a greater 
extent than observed with mPQ treatment (Fig 
3C).  
Since insulin-responsive GLUT4 
trafficking is selectively impaired in adipocyte 
insulin resistance (23), we assessed insulin 
action by cell-surface glucose transporter 
activity (24,25). Contrary to our model (Fig 
3A), we did not observe any detectable 
inhibition of insulin action by DCA treatment, 
with only mPQ causing insulin resistance 
within this acute time-frame (Fig 3D). This 
concurred with the presence of glucose and/or 
DCA having no consistent effect on insulin-
stimulated signalling as measured by Akt and 
its substrate, AS160 (Fig 2C,E). Furthermore, 
in the presence of glucose, insulin rapidly 
stimulated GLUT4 translocation and the 
proportion of cell-surface GLUT4 did not 
decrease within 1 h (Fig 3E), which was a 
sufficient time-frame for glucose-dependent 
mitoROS levels to rise (Fig 2D). Thus, glucose-
dependent mitoROS does not appear to cause 
acute insulin resistance. 
 
MitoROS needs to increase before the insulin 
stimulus to impair insulin action 
Although insulin-dependent glucose 
metabolism increases mitoROS levels higher 
than mPQ treatment (Fig 3C), mPQ was added 
prior to the insulin treatment (as in (11)). This 
would have allowed mitoROS to increase prior 
to the insulin stimulus, unlike glucose-
dependent mitoROS (Fig 2C). Thus, mitoROS 
may need to increase prior to insulin 
stimulation to cause insulin resistance. To test 
this, we treated adipocytes with mPQ before or 
after insulin stimulation. Strikingly, mPQ pre-
treatment impaired insulin-stimulated GLUT4 
translocation (Fig 4A), but this was not 













observed when cells were treated with mPQ 
after insulin stimulation (Fig 4B). However, in 
each case, mPQ increased mitoROS levels, 
assessed by PRDX3 dimerisation (Fig 4A,B). 
Thus, our data suggest that mitoROS only leads 
to insulin resistance if mitoROS increases prior 
to insulin stimulation (Fig 4C). 
 
DISCUSSION 
In this study, we examined the 
relationship between nutrient excess and insulin 
resistance in adipocytes. We tested the concept 
of ‘glucose-dependent’ insulin resistance, 
whereby insulin-stimulated glucose 
metabolism would fuel respiration, generate 
mitoROS, and feed back to reduce glucose 
uptake. Although insulin stimulated respiration 
in the absence of glucose (Fig 1), glucose was 
required for insulin to increase mitoROS (Fig 
2). However, glucose-dependent mitoROS did 
not acutely cause insulin resistance (Fig 3) 
because mitoROS needed to increase before the 
insulin stimulus for insulin resistance to occur 
(Fig 4). This may explain why insulin-
stimulated glucose utilisation does not acutely 
cause insulin resistance in adipocytes (Fig 4C). 
Mitochondrial respiration is governed 
by nutrient supply and energy demand (12), 
permitting the mitochondrion to serve as a 
cellular sensor for energetic imbalance. Several 
observations suggest that for adipocytes 
exposed to insulin, respiration is driven by 
increased energy demand rather than substrate 
(glucose) supply. First, insulin stimulated 
respiration in both the absence or presence of 
glucose (Fig 1) and upon inhibition of glucose 
uptake (Fig S2D), and DCA treatment had no 
impact on respiration (Fig 3). Second, we 
previously showed that insulin stimulates 
anabolism before glucose uptake is maximal 
(24), corresponding with a transient decrease in 
the global energy charge in adipocytes. Here, 
we found that insulin treatment did not alter 
MMP (Fig 1), suggesting supply and demand 
are synchronised, hence respiration likely 
increases in response to the energetic demands 
of the cell. Third, although insulin stimulated 
glucose uptake by several fold (24), glucose 
only contributed a quarter of respiration-
derived CO2 upon insulin stimulation (Fig 1, 
S1). Finally, glucose only impacted respiration 
under maximal respiratory demand, whereby 
both insulin and glucose were required to 
increase further respiration in the presence of an 
uncoupler (Fig 1). Indeed, treatment with a 
mitochondrial uncoupler increased glucose 
oxidation substantially higher than insulin 
alone (21). Collectively, this suggests that 
insulin stimulates energy demand in 
adipocytes, but this increased demand is not 
enough to require substrate supply from 
exogenous glucose. 
The minor contribution of glucose to 
respiration-derived CO2 (Fig 1G) concurs with 
our previous tracer metabolomics analysis of 
insulin-stimulated adipocytes (24) – for 
instance, with insulin treatment, the unlabelled 
isotopologue of acetyl CoA was dominant, 
suggesting other carbon sources contributed 
substantially to the Krebs cycle. Given that 
insulin inhibits glycogen breakdown and 
lipolysis, this leaves amino acids as a potential 
respiratory substrate. Indeed, previous stable-
isotope tracer  studies that demonstrated that in 
adipocytes, the Krebs cycle can be fuelled by 
branched chain amino acids and glutamine 
(26,27). This provides a likely explanation for 
how insulin stimulated respiration in the 
absence of glucose (Fig 4C), by accessing 
carbon from amino acids for the Krebs cycle. 
Overall, these findings suggest that insulin 
plays a much larger role in directing cellular 
metabolism beyond stimulating glucose uptake, 
coordinating the oxidation of other substrates to 
fuel the energy demands of anabolism.  
In contrast, glucose was specifically 
required for the insulin-stimulated increase in 
mitoROS, which was ablated by the absence of 
glucose or inhibition of glucose uptake, and 
accentuated by DCA treatment (Fig 2). Given 
that insulin suppresses lipid breakdown by anti-
lipolysis, this together implies that the 
remaining substrates (e.g., amino acids in the 
DMEM buffer) do not contribute to insulin-
stimulated oxidant production. Furthermore, 
PRDX3 dimerisation only increased when a 
threshold of glucose uptake was reached (Fig 
2H), suggesting that mitoROS generated below 
this threshold can be adequately buffered by the 
adipocyte. Upon acute insulin stimulation, we 
speculate that sites of glucose-dependent 
mitoROS production would either be pyruvate 
dehydrogenase or mitochondrial glycerol 3-
phosphate dehydrogenase (19,28), which 
represent more ‘glucose-specific’ sites of entry 
into mitochondrial respiration.  
Collectively, these data demonstrate a 
disconnect between mitochondrial respiration 
and oxidant production (Fig 4C). Although both 
respiration and mitoROS generation occur in 













the mitochondria, they differ in their substrate 
requirements, with only mitoROS levels 
increasing in the presence of glucose. 
Specifically, respiration responds to increases 
in energy demand, whereas mitoROS levels 
respond to increases in glucose supply. We 
believe that this disconnect between respiration 
and mitoROS enables adipocytes to distinguish 
between energetic demand and nutrient supply, 
finetuning its metabolism and insulin 
sensitivity to different nutritional and hormonal 
cues.  
Although mitoROS are implicated in 
insulin resistance (8), glucose-dependent 
mitoROS did not acutely lead to insulin 
resistance (Fig 3). In contrast, treatment with 
mPQ in a similarly short time-frame was 
sufficient to induce insulin resistance (8). We 
subsequently found that mitoROS needed to 
increase prior to the insulin stimulus to induce 
insulin resistance (Fig 4). Although we cannot 
exclude the possibility that glucose oxidation 
and mPQ treatment generate different oxidant 
species and/or oxidants that arise from different 
cellular locations, our findings suggest that 
there is a temporal requirement for mitoROS to 
cause insulin resistance. Specifically, as 
mitoROS outweighs endogenous scavenging 
systems, the mitoROS likely reacts with a 
macromolecule required in the initial stages of 
insulin-stimulated glucose transport. 
Furthermore, since oxidative stress does not 
require long-term adaptive changes such as 
transcriptional modification to cause insulin 
resistance in adipocytes (29), it is likely to 
cause rapid changes in kinase signalling and/or 
GLUT4 trafficking. However, mitoROS did not 
affect Akt signalling (Fig 3), concurring with 
previous studies (11). Thus, it is tempting to 
speculate that mitoROS specifically blocks the 
insulin-dependent mobilisation of GLUT4 to 
the cell surface (e.g., exocytosis of GLUT4-
containing vesicles), rather than steps involved 
in the maintenance of enhanced PM GLUT4 
during an insulin stimulus, such as the recycling 
of PM GLUT4 via endosomes. 
Teleologically, this temporal 
requirement for mitoROS suggests that the 
adipocyte needs to sense excess nutrient supply 
prior to the insulin stimulus in order to trigger 
insulin resistance. This is consistent with a 
model whereby consumption of a meal will not 
impair insulin action whereas oxidative stress 
upon chronic over-nutrition would lead to a 
persistent decrease in insulin action. This raises 
the question, what physiological substrate(s) 
are oxidised to cause oxidant-induced insulin 
resistance (Fig 4C)? One strong candidate are 
fatty acids, since fatty acid oxidation has been 
demonstrated to impair insulin-stimulated 
glucose uptake in myotubes, and muscle tissue 
in rodents and human subjects (e.g., (6,30,31)). 
Also, insulin suppresses lipolysis – conversely, 
fatty acid oxidation would be elevated when 
insulin levels are low, providing a source of 
mitoROS prior to an insulin stimulus. This may 
explain why both long-term fasting (sustained 
lipolysis) and Western diets (high fat) both 
cause insulin resistance, in isolated rat 
adipocytes (32-35) and at the whole-body level 
(reviewed in (8)). Ultimately, this would 





The following chemicals were used in 
this study: insulin (Sigma-Aldrich #I5500), 
dichloroacetate (sodium salt, Sigma-Aldrich 
#347795), oligomycin (Sigma-Aldrich 
#O4876), rotenone (Sigma-Aldrich #R8875), 
antimycin A (Sigma-Aldrich #A8674), and 
cytochalasin B (Sigma-Aldrich #C6762). In 
addition, BAM15 (36) was a gift from Dr Kyle 
Hoehn (The University of New South Wales, 
Sydney, Australia) and mPQ (37) was a gift 
from Dr Mike Murphy (University of 
Cambridge, Cambridge, United Kingdom). 
Matrix-roGFP was a gift from Paul Schumacker 





3T3-L1 fibroblasts were cultured as 
described previously (38), using Media A, 
consisting of bicarbonate-buffered DMEM 
(Life Technologies, #11960), supplemented 
with 10% (v/v) foetal bovine serum (Life 
Technologies, #16000044) and 2 mM 
GlutaMAX (Life Technologies, #35050061). 
3T3-L1 fibroblasts were differentiated into 
adipocytes as described previously (24,38). 
Adipocytes were used between days 9-12 after 
the initiation of differentiation. At least 90% of 
the cells were differentiated prior to 
experiments. These cells were routinely tested 
for mycoplasma infection. 
Unless otherwise specified, prior to 
insulin stimulation treatments, cells were 













serum-starved for at least 2 h. This involved 
washing cells three times with PBS and 
incubating them in basal media. By default, the 
basal media was Media B, which consisted of 
bicarbonate-buffered DMEM (Life 
Technologies #11960), supplemented with 
0.2% (w/v) bovine serum albumin (BSA, 
Bovostar) and 2 mM GlutaMAX. 
For experiments within the CO2 
incubator that involved treatment with different 
sugars, cells were washed twice after serum-
starvation: once with PBS, then with BSF-
DMEM, which consisted of substrate-free 
DMEM (Sigma #D5030), supplemented with 
44 mM NaHCO3 and adjusted to pH 7.4 with 
CO2 (dry ice). Cells were then incubated in 
Media BS, which consisted of BSF-DMEM, 
supplemented with 0.2% (w/v) BSA, 1 mM 
GlutaMAX, 1 mM glutamine, and sugar 
(glucose/galactose) as specified in the figure 
legends. The supplementation of glutamine in 
addition to GlutaMAX served to provide an 
immediate source of glutamine substrate for 
experiments involving early time-points.   
For metabolic assays performed 
outside of the CO2 incubator, cells were washed 
twice after serum-starvation: once with PBS, 
then with HSF-DMEM, which consisted of 
substrate-free DMEM (Sigma-Aldrich 
#D5030) supplemented with 30 mM Na-
HEPES (pH 7.4) and adjusted to pH 7.4 with 
NaOH. Cells were then incubated in Media C, 
which consisted of HSF-DMEM, supplemented 
with 0.2% (w/v) BSA, 1 mM NaHCO3 (added 
fresh), 1 mM glutamine, 1 mM GlutaMAX, and 
sugars (glucose/galactose) as specified in the 
figure legends. Alternatively, cells were 
assayed in Media CX, which consisted of 
Media C without BSA, as specified in the figure 
legends.   
 
Quantification of lactate content  
 Lactate content was assayed 
enzymatically using the hydrazine sink method, 
as described previously (21,39). 
 
Quantification of glucose uptake 
Glucose uptake was determined by 
measuring the disappearance of media glucose, 
as described previously (21,24). This differs 
from the measurement of glucose transport, 
which is described below. 
 
Respirometry using the XFp Analyzer 
(Seahorse BioSciences)  
On Day 7-8 of differentiation, 3T3-L1 
adipocytes were seeded onto XFp plates 
described previously (14). Cells were prepared 
for the assay as described previously (14), with 
minor modifications. Specifically, cells were 
washed 4 times with PBS before incubation in 
Media C, supplemented with 25 mM glucose, 
for at least 1.5 h in a non-CO2 incubator at 37
 
°C. Cells were then washed once with PBS, 
once with HSF-DMEM, and incubated in 
Media CX (150 μl/well), supplemented with 25 
mM sugar (glucose/galactose). Cells were then 
assayed in the XFp Analyzer: following a 12 
min equilibration period, respiration and 
extracellular acidification rates were measured 
with mix/wait/read cycles of 3/0/2 min. 
Following stabilisation of baseline rates, 
compounds were injected sequentially as 
indicated in the figures. Flux rates were 
normalised to cellular DNA content, the latter 
being quantified as described below.  
 
Measurement of mitochondrial membrane 
potential  
 Mitochondrial membrane potential was 
assessed using the ‘quenching method’ with 
tetramethylrhodamine methyl ester (TMRM) 
dye (40). 3T3-L1 adipocytes were seeded into 
black 96-well plates (Corning), pre-coated with 
Matrigel (Corning), in a similar manner as 
seeding into XFp plates (above). On the day of 
the experiment, cells were washed 4 times with 
PBS (150 μl per wash) before incubation in 
Media C, supplemented with 25 mM glucose, 
for at least 1.5 h in a non-CO2 incubator at 37 
°C. In the last 30 min of this serum starvation 
period, cells were labelled with 500 nM TMRM 
(or DMSO control – ‘TMRM-free’).  
Cells were then washed twice with 
PBS, once with HSF-DMEM, then incubated in 
90 μl Media CX per well. The plate was 
incubated at 37 °C in the FLUOstar Omega 
microplate reader (BMG Labtech). 
Fluorescence was measured every 90 s using 
the top optic at 544 nm excitation and 590 nm 
emission, with 20 flashes per well. This pre-
read period was conducted for 15 min to ensure 
a stable baseline measurement was achieved for 
each well. Drugs were added in the following 
sequence in 10 μl, followed by fluorescence 
measurement (with final drug concentrations 
and treatment times indicated in the figure): 
glucose or galactose; insulin or naïve media 
control; oligomycin, BAM15, or DMSO 
control.  













At the end of the experiment, aliquots 
of media were taken from the wells treated with 
DMSO (i.e., glucose/galactose, insulin/control) 
and assessed for lactate content (described 
above) to check that insulin and sugar responses 
were similar to Fig. 1A (data not shown). 
Fluorescence measurements were first 
adjusted by the fluorescence of identically-
treated cell-free and TMRM-free controls, to 
account for background fluorescence. Next, 
measurements were normalised to the last 
measurement of the pre-read period, to account 
for well-to-well differences in TMRM 
labelling. Finally, these values were normalised 
to the glucose-control-DMSO condition, to 
account for changes in signal independent of 
drug treatments. This normalised measurement 
was denoted ‘relative TMRM signal’.  
 
Measurement of glucose oxidation and PPP 
flux 
 Following serum-starvation in Media 
B, cells were incubated with Media C 
supplemented with 10 mM glucose, and either 
0.5 µCi/ml [1-14C]-, 1 µCi/ml [6-14C]-, or 1 
µCi/ml [U-14C]-glucose tracer. Following the 
addition of drug treatments, glucose oxidation 
was assessed as described previously (13,21) – 
briefly, a gas-trap was installed in each well, 
plates were sealed, and following treatment 
cells were quenched by acidification. 
Radioactivity of the gas-trapping solution was 
measured by liquid scintillation counting and 
adjusted to cell-free controls.  
 Total glucose oxidation was derived 
from the use of [U-14C]-glucose tracer and PPP 
flux was derived from the use of [1-14C]- and 
[6-14C]-glucose tracers (41,42). Calculating 
PPP flux also required the rate of glucose 
uptake and protein content, which were derived 
from cells treated in parallel (in the absence of 
radiolabel or gas-trap installed). Glucose uptake 
was determined as described above, and protein 
content was determined as described below 
after washing cells thrice with ice-cold PBS and 
lysis in PBS containing 1% (v/v) Triton X-100.  
 
Assessment of insulin action by glucose 
transporter activity  
Glucose transporter activity was 
measured as described previously (24). Briefly, 
following treatment, cells were washed with 
ice-cold PBS, incubated in cold Krebs-Ringer 
phosphate buffer (24) without any drugs, and 
assessed for 2-deoxyglucose uptake on ice. 
These cold conditions ensured the rate of 
uptake was solely dependent on the membrane 
trafficking, and movement of glucose 
transporters to the cell surface, that had 
occurred during the treatment period (but not 
the 2-deoxyglucose uptake period).  
 
Assessment of insulin action by GLUT4 
translocation 
GLUT4 translocation in 3T3-L1 
adipocytes was measured as described 
previously (11). Briefly, 3T3-L1 fibroblasts 
were retrovirally-infected with a construct 
expressing HA-tagged GLUT4, differentiated, 
and seeded into black 96-well plates. Following 
treatment, the quantity of cell-surface HA was 
assessed by immunofluorescence staining and 
normalised to total HA content (11).  
 
Normalisation for cell culture experiments 
Flux rates were normalised to cellular 
protein or DNA content, using cell lysate 
derived from the respective assay or from cells 
treated in parallel. Unless otherwise specified, 
flux rates were normalised to protein content, 
determined using the Pierce bicinchoninic acid 
assay kit (ThermoFisher) according to the 
manufacturer’s instructions. If flux rates were 
normalised to DNA, the DNA quantification 
was performed following cell lysis by repeated 
freeze-thaw, using Hoechst staining as 
described previously (21).  
 
Western blotting 
Following treatment, cells were 
harvested for protein and lysates subjected to 
Western blotting as described previously (11). 
Antibodies detecting pS473-Akt (clone 
587F11, catalog #4051), pT308-Akt (catalog 
#9275), Akt (clone 11E7, catalog #4685), and 
pT642-AS160 (catalog #4288) were obtained 
from Cell Signaling Technology. The 
antibodies detecting PDH-E1α (clone H-131, 
catalog #sc292543) and 14-3-3 (clone K-19, 
catalog #sc-629) was obtained from Santa Cruz 
Biotechnology. The antibody detecting pS293-
PDH-E1α (catalog #ABS204) was obtained 
from Millipore. The antibody detecting PRDX3 
(catalog #LF-PA0030) was obtained from Life 
Technologies. The antibody detecting PRDX2 
(clone EPR5154, catalog #ab109367) was 
obtained from Abcam. Densitometric analysis 
was performed either using Fiji software (43) or 
LICOR Image Studio.  
 













Assessment of mitochondrial oxidative stress 
by microscopy 
3T3-L1 adipocytes were electroporated 
and imaged as described previously (44). On 
Day 7 of differentiation, 3T3-L1 adipocytes 
were tryspinised, pelleted at 150 g for 5 min, 
and washed 3 times with PBS before 
resuspension in electroporation solution (20 
mM HEPES, 135 mM KCl, 2 mM MgCl2, 0.5% 
(w/v) Ficoll 400, 1% (v/v) DMSO, 2 mM ATP 
and 5 mM glutathione, pH 7.6) and 5 μg of 
plasmid DNA (matrix-roGFP). Cells were then 
electroporated at 200 mV for 20 ms and plated 
onto Matrigel-coated 35 mm Ibidi glass-bottom 
m-Dishes dishes.  
Imaging experiments were performed 
24 h post-electroporation. Cells were serum-
starved in Media B and imaged in Fluorobrite 
DMEM (Life Technologies), supplemented 
with 0.2% (w/v) BSA and 2 mM GlutaMAX, 
under 10% CO2. Imaging was performed on a 
Nikon Ti inverted microscope equipped with a 
Spectral Applied Research Diskovery spinning 
disk module and an Okolab cage incubator 
maintained at 37 °C. Drugs were added using a 
custom-made perfusion system. Image analysis 
was performed in Fiji (43) using a scripted 
analysis pipeline. 
 
Quantification of the contribution of glucose 
to respiration-derived CO2  
Our approach (Fig 1G) was based on 
the principle that ECAR is influenced by both 
lactate production and bicarbonate derived 
from CO2 release (18). This required several 
sets of flux data (ECAR, lactate production, and 
glucose oxidation), each derived from separate 
batches of cells. These flux parameters, when 
measured in insulin-stimulated 3T3-L1 cells (in 
Media C), typically varied by <20% between 
batches of cells (data not shown).  
To quantify the contribution of glucose 
to respiration-derived CO2, the following steps 
were performed: 
(i) The total ECAR (mpH/h) was 
derived from flux data (e.g., Fig S1A). Since 
ECAR initially rises before reaching a plateau 
with insulin treatment, total ECAR was 
determined by calculating the area-under-the-
curve using the trapezoidal rule. Since maximal 
ECAR remains constant for at least an hour 
after insulin stimulation (data not shown), 
ECAR flux was extrapolated to 1 h using the 
last three timepoints at the maximal rate if 
complete data was not available. 
(ii) The buffering capacity (BF) of the 
media (Fig S1B) was determined by incubating 
naïve media in the Seahorse XFp and 
measuring pH changes following repeated 
injections of 1 M NaOH or HCl. Close to the 
pKa, the buffering curve is ‘pseudo-linear’ (18) 
and thus the gradient can be used to determine 
buffering capacity (μM H+/mpH, i.e. change in 
[H+] per change in pH).  
(iii) The proton production rate (PPR, 
changes in media [H+] in an XFp well) was 
determined from the ECAR (changes in media 
pH), using the media buffering capacity, 
measurement chamber volume, and Kvol 
adjustment factor (45):  
PPR (pmol H+/h) = ECAR (mpH/h) . BF 
(μM H+/mpH) . volume (2.28 μl) . Kvol 
(1.19) 
(iv) Next, we obtained lactate 
production data (21), which involved 3T3-L1 
cells treated with 100 nM insulin for 1 h in 
Media C, supplemented 25 mM glucose. The 
cells were treated under slightly different 
conditions (e.g., plate format, presence of BSA 
in assay media), but these parameters did not 
impact insulin-stimulated lactate production 
(Fig S1C). The lactate production data was 
scaled down to the cell number in a well of an 
XFp plate.  
(v) Bicarbonate production was 
determined from the PPR and lactate 
production data. Since each lactate molecule is 
effluxed with 1 proton and the conversion of 
CO2 into NaHCO3 generates 1 proton, these 
outputs are stoichiometrically 1-to-1 with PPR. 
Thus, we calculated bicarbonate production as 
the difference between PPR and lactate 
production:  
NaHCO3 production (pmol H
+/h) = PPR 
(pmol H+/h) – lactate production (pmol 
H+/h) 
We assumed that other sources of proton efflux 
were negligible (18). 
(vi) Total CO2 production was 
determined from bicarbonate production by 
accounting for the solubility of bicarbonate in 
water (18).  
(vii) The contribution of glucose to 
CO2 production was calculated using 
measurements of the incorporation of 14C-
radiolabelled glucose into CO2 (21). Briefly, 
3T3-L1 cells were treated with 100 nM insulin 
for 1 h in Media C, supplemented with 25 mM 
glucose and [U-14C]-glucose tracer. This value 
was scaled down to the cell number in a well of 













an XFp plate, and multiplied by 6 (1 glucose 
generates 6 CO2) to obtain the production rate 
of glucose-derived CO2. 
(viii) Since CO2 can be generated by 
the pentose phosphate pathway (PPP) in 
addition to respiration, we compared the 
incorporation of glucose into CO2 versus PPP 
flux (Fig S1D). PPP flux was stimulated by 
insulin and abolished with an inhibitor of 6-
phosphogluconate dehydrogenase, 6-
aminonicotinamide (Fig S1D). Nevertheless, 
PPP-derived CO2 was negligible compared to 
the total incorporation of glucose into CO2 
(performed in parallel, Fig S1D), considering 
that PPP generates 1 CO2 per glucose molecule 
compared to 6 CO2 via respiration. Thus, it was 
assumed that glucose-derived CO2 was solely 
derived from respiration.  
(ix) Glucose-derived CO2 production 
was compared to total CO2 production, yielding 
the contribution of glucose to respiration-
derived CO2. 
 
Metabolic assays in primary adipocytes 
Isolation and assay buffers 
Buffers included Krebs-Henseleit 
buffer (KHB: 120 mM NaCl, 4.7 mM KCl, 1.18 
mM KH2PO4, 1.17 mM MgSO4, 1.8 mM CaCl2, 
30 mM Na-HEPES, 1 mM NaHCO3 (added 
fresh), 1% (w/v) fatty-acid-free BSA (Sigma), 
pH adjusted to 7.4 with NaOH), KHB-Glc 
buffer (KHB, supplemented with 10 mM 
glucose), and assay buffer (HSF-DMEM, 
supplemented with 1 mM NaHCO3 (added 
fresh), 1 mM glutamine, 1 mM GlutaMAX, and 
1% (w/v) fatty-acid-free BSA, with pH adjusted 
to 7.4 with NaOH). All buffers were maintained 
at 37 °C throughout the experiment.  
 
Isolation of mature primary adipocytes 
Male Sprague Dawley rats were housed 
at 23 °C in individually ventilated cages on a 
12-hour light:dark cycle with ad libitum access 
to standard rodent chow and water. Rat 
experiments were approved by the University 
of Sydney Animal Ethics Committee (project 
#2018/1418). At 7-8 weeks of age (200-300 g), 
rats were sacrificed with CO2. Mature primary 
adipocytes were isolated, as described 
previously (21). Briefly, epidydimal fat pads 
were isolated and collagenase-digested in 
KHB-Glc buffer. The isolated adipocytes were 
washed twice with KHB and then twice with 
assay buffer, to remove collagenase, non-
adipocyte cells, and glucose from the digestion 
buffer. After the final wash, the infranatant was 
removed and aliquots of adipocyte suspension 
were used in the assays below.  
 
Respirometry of primary adipocytes using the 
O2k oxygraph (Oroboros)  
 High resolution oxygen consumption 
measurements were conducted using the O2K 
oxygraph (series H). 200-400 µl of primary 
adipocyte suspension were loaded into each 
O2K chamber, made up to a final volume of 2.1 
ml with assay media supplemented with a (final 
concentration) of 5 mM glucose or galactose. 
Experiments were conducted at 37 °C with 
stirring at 750 rpm stirring and data recording 
at 2 s intervals. Cells were allowed to 
equilibrate prior to the sequential addition of 
pharmacological agents as indicated in the 
figure legends. Respiratory flux data was 
analysed using DatLab 7.3.0.3 (Oroboros).  
Following the experiment, aliquots (3x 
500 µl) of cell suspension were taken from each 
chamber and immediately frozen. DNA was 
isolated under high salt conditions with organic 
extraction, similar in principle to what has been 
described previously (21). After the addition of 
0.2 vol of 5 M NaCl and mixing, an equal 
volume (600 µl) of CHCl3 was added. Samples 
were mixed thoroughly and centrifuged for 20 
min at 16,000 x g and 4 °C. The supernatant was 
assayed for DNA content using SyBr stain (Life 
Technologies), according to the manufacturer’s 
instructions. Fluorescence measurements were 
compared to a standard curve of salmon sperm 
DNA, spiked with naïve assay buffer extracted 
alongside adipocyte samples. Furthermore, 
extraction efficiency was determined by 
spiking one aliquot of adipocyte suspension 
from each O2K chamber (out of three) with 
salmon sperm DNA prior to extraction.  
Respiration fluxes were normalised to 
DNA content and then to the baseline 
respiration of the chamber receiving the glucose 
+ insulin condition.  
 
Lactate measurement in primary adipocytes 
Adipocytes were assessed for lactate 
production as described previously (21), with 
slight modifications. Briefly, 200 µl of 
adipocyte suspension was dispensed into wells 
of 24-well polystyrene, tissue culture 
microplates (Corning). To each well, 50 µl of 
pre-warmed assay buffer containing glucose or 
galactose, and PBS control or insulin, was 
added. As a result, each well contained a final 













volume of 250 µl, with 5 mM sugar and either 
PBS control or 20 nM insulin. Plates were then 
immediately sealed with TopSeal-A PLUS 
(PerkinElmer) and gently rocked for 1 h with a 
rocking platform in a 37 °C incubator.  
Following incubation, cells were 
immediately quenched by the addition of 400 μl 
MeOH, followed by 400 µl water. Lysates were 
transferred to tubes, 800 µl CHCl3 was added, 
and samples were vortexed briefly prior to 
centrifugation for 20 min at 16,000 x g and 4 
°C. The supernatant was lyophilised using an 
EZ-2 centrifugal evaporator (GeneVac), 
resuspended in water, and assayed for lactate 
content enzymatically as described above and 
previously (21).  
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Figure 1. Glucose is dispensable for insulin-stimulated respiration in adipocytes. A, 3T3-L1 
adipocytes were treated for 1 h with or without 100 nM insulin (Ins) in Media BS, supplemented with 
25 mM glucose (Glc) or galactose (Gal). Following treatment, lactate production was quantified 
enzymatically as described in the Experimental Procedures. Data presented as mean + SEM, from 3 
separate experiments. B, 3T3-L1 adipocytes were incubated in Media CX supplemented with 25 mM 
Glc or Gal, and cellular respiration (JO2) was measured using the XFp Analyzer following sequential 
treatment with (or without) Ins (100 nM), oligomycin (Oligo, 10 µg/ml), BAM15 (10 µM), rotenone 
(Rot, 5 µM), and antimycin A (AA, 10 µM) at the time-points indicated. Data presented as mean ± 
SEM, from 4 separate experiments. C, 3T3-L1 adipocytes were pre-loaded with TMRM dye, and 
fluorescence was measured following incubation in Media CX supplemented with 25 mM Glc or Gal, 
treatment with Ins (100 nM), and treatment with Oligo (10 µg/ml) and BAM15 (10 µM) as indicated. 
Fluorescence was normalised to the Glc/control condition (details in the Experimental Procedures). 
Data presented as mean ± SEM, from 5 separate experiments. MMP, mitochondrial membrane 
potential. D-F, Mature primary adipocytes were isolated from rats and incubated in assay media 
supplemented with 5 mM glucose (Glc) or galactose (Gal). In D, adipocytes were treated without 
(control, Ctrl) or with Ins (20 nM) for 1 h. Following treatment, lactate content was determined 
enzymatically following MeOH-CHCl3 extraction and normalised to the Glc/Ins condition. Data 
presented as mean + SEM, from 3 separate experiments. In E, respiration was measured using the 
Oroboros O2K following the addition of Ins (20 nM), Oligo (5 µg/ml), carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP, concentrations as indicated), Rot (10 µM), and AA (25 
µM). Respiration was normalised to the baseline respiration of the Glc/Ins condition. Data presented as 
mean + half-range, from 2 separate experiments. In F, respiration was measured as in (E). Data 
presented as mean + SEM, from 4 separate experiments. G, Schematic depicting how the contribution 
of glucose to respiration-derived CO2 was determined using ECAR (extracellular acidification rate), 
lactate production, and glucose oxidation data. Details in the main text. Data presented as mean ± SEM, 
derived from experiments cited in the main text. AUC, area under the curve; PPR, proton production 
rate.  
 
Figure 2. Glucose is required for insulin to increase mitochondrial oxidant levels. A-B, 3T3-L1 
adipocytes were incubated in Media CX supplemented with 25 mM glucose (Glc) or galactose (Gal), 
and extracellular acidification rate (ECAR, A) or cellular respiration (JO2, B) was measured using the 
XFp Analyzer following sequential treatment with insulin (Ins, 100 nM), dichloroacetate (DCA, 1 mM), 
oligomycin (Oligo, 10 µg/ml), and BAM15 (10 µM). Data presented as mean ± SEM, from 4 separate 
experiments. C, 3T3-L1 adipocytes were serum-starved in Media BS with 25 mM Glc. During the last 
1 h of serum-starvation, cells were pre-treated with DCA (1 mM) or antimycin A (AA, 50 nM). Cells 
were then incubated in Media BS, supplemented with 25 mM Glc or Gal, with Ins (100 nM) and DCA 
(1 mM) for the indicated times. Following treatment, cells were harvested and lysates were subjected 
to Western blotting with antibodies against the indicated proteins. Data representative of 4 separate 
experiments. D, dimer; M, monomer. D, Densitometry of PRDX2 and PRDX3 bands from (C), 
expressed as a ratio of dimer to monomer bands, and made relative to the treatment with Glc at t=0 min. 
Data presented as mean ± SEM, from 4 separate experiments. E, Densitometry of the indicated proteins 
from (C), normalised to α-tubulin and made relative to the Glc/t=20 min condition. Data presented as 
mean ± SEM, from 4 separate experiments. F, 3T3-L1 adipocytes were serum-starved, then incubated 
in Media BS with Ins (100 nM), AA (50 nM), and/or cytochalasin B (CB, 25 µM). This treatment media 
was also supplemented with the indicated concentration of Glc, with the final volume balanced with 
either water or Gal (for the latter, the final combined sugar concentration was 25 mM). Following 1 h 
of treatment, cells were harvested and lysates subjected to Western blotting with antibodies against the 
indicated proteins. Data representative of 4 separate experiments. G, Densitometry of PRDX3 bands 
from (F), expressed as the ratio of dimer to monomer bands, and made relative to the treatment with 25 
mM Glc without Ins (second lane in F). Data presented as mean ± SEM, from 4 separate experiments. 
H, PRDX3 dimerisation (G) plotted against Glc uptake (Fig S2C) for Ins-treated cells exposed to 
varying media Glc concentrations. Hill equation fitted based on individual datapoints and overlayed 
onto data, which is presented as mean ± SEM, from 4 separate experiments. 













Figure 3. Glucose-dependent mitochondrial oxidants do not cause insulin resistance. A, Schematic 
depicting how insulin-dependent glucose oxidation could lead to oxidant-induced insulin resistance. 1) 
glucose is taken up and 2) a majority is diverted to fates such as lipid or lactate production (Quek et al., 
manuscript under review; (21)). 3) A small portion of glucose is oxidised and while this does not 
contribute substantially to respiration, 4) it increases mitochondrial reactive oxygen species (ROS) 
levels, 5) eventually leading to insulin resistance. GLUT4, glucose transporter 4. B-D, 3T3-L1 
adipocytes were treated in Media B with mitoparaquat (mPQ, 20 µM), dichloroacetate (DCA, 1 mM), 
and insulin (Ins, 100 nM) at the times indicated in (B). Cells were also treated with auranofin (AF, 5 
µM) at t = 30 min (concurrently with mPQ treatment) in (C). Cells in (C) and (D) were treated in 
parallel. Following treatment, cells were either (C) harvested for protein and lysates were subjected to 
Western blotting with antibodies against the indicated proteins, or (D) assayed for 2-deoxyglucose 
uptake under cold conditions. In (C), densitometric analysis was performed as described in Fig 2D. Data 
presented as mean + SEM, from 4 separate experiments. *, p<0.05 and ns, p>0.05, by two-sample t-
test. E, 3T3-L1 adipocytes constitutively expressing HA-tagged GLUT4 were incubated in Media B 
and stimulated with insulin (Ins, 100 nM) for the indicated time-points, after which GLUT4 
translocation to the plasma membrane (PM) was measured. Data presented as mean ± SEM, from 3 
separate experiments. 
 
Figure 4. Mitochondrial oxidants need to increase prior to the insulin stimulus to cause insulin 
resistance. A-B, 3T3-L1 adipocytes constitutively expressing HA-tagged glucose transporter 4 
(GLUT4) were incubated in Media B and treated with mitoparaquat (mPQ, 20 µM) and insulin (Ins, 
100 nM) at the indicated time-points (left panel). Once a drug was added, it remained in the media for 
the remainder of the treatment period. Following treatment, cells were assayed for GLUT4 translocation 
to the plasma membrane (PM) (middle panel), or harvested and lysates were subjected to Western 
blotting with antibodies against the indicated proteins (right panel). Densitometric analysis (right panel) 
was performed as described in Fig 2D. Data in middle panel presented as mean + SEM, from 3 separate 
experiments. Data in right panel representative of 2 separate experiments. D, dimer; M, monomer. *, 
p<0.05 and ns, p>0.05, compared to Ins-treated cells, by two-sample t-test. C, Schematic depicting how 
glucose metabolism demonstrates a disconnect between insulin-stimulated mitochondrial respiration 
and oxidant production in adipocytes. Details in the main text. ROS, reactive oxygen species. 
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10 min Time (min)
AUC ECAR (888.0 ± 83.1 mpH/h)
Total PPR (28.4 ± 2.7 nmol H+/h)
Buffering capacity (11.8 µM/mpH)
Measurement volume = 2.28 µl
Kvol adjustment factor = 1.19 
Lactate production (13.1 ± 0.4 nmol/h)
PPR due to CO2 (15.3 ± 2.7 nmol H+/h)
Solubility of CO2 in water (~95.3%)
CO2 production (16.0 ± 2.8 nmol/h)
CO2 from glucose (3.2 ± 0.1 nmol/h)
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